Conference Proceedings
Long-term Efficacy and Safety of Latanoprostene Bunod 0.024% for Intraocular Pressure Lowering in Patients with Open-Angle Glaucoma or Ocular Hypertension: APOLLO and LUNAR Studies
Jason L Vittitow, Jeffrey M Liebmann, Paul L Kaufman, Felipe A Medeiros, Keith R Martin, Robert N Weinreb
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | ASSOC RESEARCH VISION OPHTHALMOLOGY INC | Published : 2016
Grants
Funding Acknowledgements
this study was sponsored by Bausch & Lomb